Home
Market Capitalization of Bharat Immunological & Biological Corporation Ltd

Bharat Immunological & Biological Corporation Ltd
NSE: BHARATIMMUNOLOG
Market Cap
Key Highlights
- The Market Cap of Bharat Immunological & Biological Corporation Ltd is ₹ 98.28 crore as of 21 Feb 25 .
- The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 22.76 as of 21 Feb 15:30 .

Bharat Immunological & Biological Corporation Ltd
NSE: BHARATIMMUNOLOG
Share Price
Market Price of Bharat Immunological & Biological Corporation Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 22.76 |
20 Feb 2025 | 22.74 |
19 Feb 2025 | 23.71 |
18 Feb 2025 | 20.87 |
17 Feb 2025 | 19.95 |
14 Feb 2025 | 22.01 |
13 Feb 2025 | 22.4 |
12 Feb 2025 | 22.76 |
11 Feb 2025 | 22.25 |
10 Feb 2025 | 23.96 |
SWOT Analysis Of Bharat Immunological & Biological Corporation Ltd
BlinkX Score for Bharat Immunological & Biological Corporation Ltd
Asset Value vs Market Value of Bharat Immunological & Biological Corporation Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Bharat Immunological & Biological Corporation Ltd
Historical P/E Ratio of Bharat Immunological & Biological Corporation Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Bharat Immunological & Biological Corporation Ltd
Historical Revenue of Bharat Immunological & Biological Corporation Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Bharat Immunological & Biological Corporation Ltd
Historical EBITDA of Bharat Immunological & Biological Corporation Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Bharat Immunological & Biological Corporation Ltd
Historical Net Profit of Bharat Immunological & Biological Corporation Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Bharat Immunological & Biological Corporation Ltd
Dividend Payout Over Time
About Bharat Immunological & Biological Corporation Ltd
- The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
- BIBCOL was incorporated in 1989.
- The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
- BIBCL installed a plant of 100 mln units.
- Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.
Bharat Immunological & Biological Corporation Ltd News Hub
Bharat Immunological & Biolog.Corp. to hold board meeting
Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the Company on
Read more
10 Aug 24
Bharat Immunological & Biological Corporation Ltd leads gainers in 'B' group
Bodhi Tree Multimedia Ltd, Mangal Credit & Fincorp Ltd, Innovana Thinklabs Ltd and Bartronics India
Read more
06 Jan 25
Bharat Immunological & Biological Corporation Ltd leads losers in 'B' group
Relicab Cable Manufacturing Ltd, Precision Wires India Ltd, Brainbees Solutions Ltd and Flair Writin
Read more
08 Jan 25